AI assistant
Sending…
Forte Biosciences, Inc. — Director's Dealing 2022
Mar 18, 2022
33769_dirs_2022-03-18_6743b110-c1fa-4625-b84b-72c44b64bfab.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Forte Biosciences, Inc. (FBRX)
CIK: 0001419041
Period of Report: 2022-03-16
Reporting Person: FINCK BARBARA K (Director)
More from Forte Biosciences, Inc.
Regulatory Filings
2026
Jun 2
Share Issue/Capital Change
2026
Jun 2
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 2
Earnings Release
2026
May 14
Capital/Financing Update
2026
Apr 9
Capital/Financing Update
2026
Apr 9
Capital/Financing Update
2026
Apr 8
Regulatory Filings
2026
Apr 1
Major Shareholding Notification
2026
Jan 29
Major Shareholding Notification
2026
Jan 20